Lyra Therapeutics, Inc.

Historical 13F Holders

Symbol
LYRA
CUSIP
55234L105
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 60 25.6 M $3.23 M
2024 Q4 56 26.9 M $5.55 M
2024 Q3 66 32.6 M $8.37 M
2024 Q2 58 33.6 M $9.29 M
2024 Q1 87 45.8 M $285 M
2023 Q4 67 46.5 M $243 M
2023 Q3 49 31.9 M $125 M
2023 Q2 43 33.7 M $138 M
2023 Q1 34 18.9 M $38.1 M
2022 Q4 42 19.1 M $60.0 M
2022 Q3 40 19.2 M $96.0 M
2022 Q2 39 19.3 M $109 M
2022 Q1 29 5.02 M $20.2 M
2021 Q4 37 8.37 M $36.5 M
2021 Q3 38 6.67 M $60.8 M
2021 Q2 48 10.2 M $81.9 M
2021 Q1 52 10.8 M $125 M
2020 Q4 46 8.60 M $98.0 M
2020 Q3 41 7.66 M $85.7 M
2020 Q2 44 7.04 M $79.8 M